Skip to main content
SpringerLink
Log in

Fatty acid amide hydrolase inhibition alleviates anxiety-like symptoms in a rat model used to study post-traumatic stress disorder

Psychopharmacology Aims and scope Submit manuscript

Cite this article

Abstract

Background and aim

Post-traumatic stress disorder (PTSD), a chronic debilitating condition that affects nearly 5–10% of American adults, is treated with a handful of FDA-approved drugs that provide at best symptomatic relief and exert multiple side effects. Preclinical and clinical evidence shows that inhibitors of the enzyme fatty acid amide hydrolase (FAAH), which deactivates the endocannabinoid anandamide, exhibit anxiolytic-like properties in animal models. In the present study, we investigated the effects of two novel brain-permeable FAAH inhibitors – the compounds ARN14633 and ARN14280 – in a rat model of predator stress-induced long-term anxiety used to study PTSD.

Methods

We exposed male Sprague–Dawley rats to 2,5-dihydro-2,4,5-trimethylthiazoline (TMT), a volatile constituent of fox feces, and assessed anxiety-like behaviors in the elevated plus maze (EPM) test seven days later. We measured FAAH activity using a radiometric assay and brain levels of FAAH substrates by liquid chromatography/tandem mass spectrometry.

Results

Rats challenged with TMT developed persistent (≥ 7 days) anxiety-like symptoms in the EPM test. Intraperitoneal administration of ARN14633 or ARN14280 1 h before testing suppressed TMT-induced anxiety-like behaviors with median effective doses (ED50) of 0.23 and 0.33 mg/kg, respectively. The effects were negatively correlated (ARN14663: R2 = 0.455; ARN14280: R2 = 0.655) with the inhibition of brain FAAH activity and were accompanied by increases in brain FAAH substrate levels.

Conclusions

The results support the hypothesis that FAAH-regulated lipid signaling serves important regulatory functions in the response to stress and confirm that FAAH inhibitors may be useful for the management of PTSD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

Data will be made available upon reasonable request.

References

  • Ahern GP (2003) Activation of TRPV1 by the satiety factor oleoylethanolamide. J Biol Chem 278:30429–30434

    Article  CAS  PubMed  Google Scholar 

  • Alexander W (2012) Pharmacotherapy for Post-traumatic Stress Disorder In Combat Veterans: Focus on Antidepressants and Atypical Antipsychotic Agents. P T 37:32–38

    PubMed  PubMed Central  Google Scholar 

  • American Psychiatric Association (2022). Trauma- and Stressor-Related Disorders. In Diagnostic and statistical manual of mental disorders (5th ed., text rev.)

  • Bluett RJ, Gamble-George JC, Hermanson DJ, Hartley ND, Marnett LJ, Patel S (2014) Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation. Transl Psychiatry 4:e408

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bortolato M, Mangieri RA, Fu J, Kim JH, Arguello O, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D (2007) Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. Biol Psychiatry 62:1103–1110

    Article  CAS  PubMed  Google Scholar 

  • Carobrez AP, Bertoglio LJ (2005) Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 29:1193–1205

    Article  CAS  PubMed  Google Scholar 

  • Cohen H, Yehuda R (2011) Gender differences in animal models of posttraumatic stress disorder. Dis Markers 30:141–150

    Article  PubMed  PubMed Central  Google Scholar 

  • Connor M, Vaughan CW, Vandenberg RJ (2010) N-acyl amino acids and N-acyl neurotransmitter conjugates: neuromodulators and probes for new drug targets. Br J Pharmacol 160:1857–1871

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cukor J, Wyka K, Jayasinghe N, Difede J (2010) The nature and course of subthreshold PTSD. J Anxiety Disord 24:918–923

    Article  PubMed  Google Scholar 

  • Danandeh A, Vozella V, Lim J, Oveisi F, Ramirez GL, Mears D, Wynn G, Piomelli D (2018) Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety. Psychopharmacology 235:3211–3221

    Article  CAS  PubMed  Google Scholar 

  • Ferguson JM (2001) SSRI Antidepressant Medications: Adverse Effects and Tolerability. Prim Care Companion J Clin Psychiatry 3:22–27

    PubMed  PubMed Central  Google Scholar 

  • Fidelman S, Mizrachi Zer-Aviv T, Lange R, Hillard CJ, Akirav I (2018) Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD. Eur Neuropsychopharmacol 28:630–642

    Article  CAS  PubMed  Google Scholar 

  • Fotio Y, Jung KM, Palese F, Obenaus A, Tagne AM, Lin L, Rashid TI, Pacheco R, Jullienne A, Ramirez J, Mor M, Spadoni G, Jang C, Hohmann AG, Piomelli D (2021) NAAA-regulated lipid signaling governs the transition from acute to chronic pain. Sci Adv 7:eabi8834

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gaetani S, Cuomo V, Piomelli D (2003) Anandamide hydrolysis: a new target for anti-anxiety drugs? Trends Mol Med 9:474–478

    Article  CAS  PubMed  Google Scholar 

  • Glaser R, Kiecolt-Glaser JK (2005) Stress-induced immune dysfunction: implications for health. Nat Rev Immunol 5:243–251

    Article  CAS  PubMed  Google Scholar 

  • Glass M, Dragunow M, Faull RL (1997) Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77:299–318

    Article  CAS  PubMed  Google Scholar 

  • Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, Cassano T, Morgese MG, Debonnel G, Duranti A, Tontini A, Tarzia G, Mor M, Trezza V, Goldberg SR, Cuomo V, Piomelli D (2005) Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci U S A 102:18620–18625

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Godlewski G, Offertaler L, Wagner JA, Kunos G (2009) Receptors for acylethanolamides-GPR55 and GPR119. Prostaglandins Other Lipid Mediat 89:105–111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gorzalka BB, Hill MN (2009) Integration of endocannabinoid signaling into the neural network regulating stress-induced activation of the hypothalamic-pituitary-adrenal axis. Curr Top Behav Neurosci 1:289–306

    Article  CAS  PubMed  Google Scholar 

  • Greco R, Demartini C, Zanaboni AM, Francavilla M, Reggiani A, Realini N, Scarpelli R, Piomelli D, Tassorelli C (2022) Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine. J Headache Pain 23:79

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Griebel G, Stemmelin J, Lopez-Grancha M, Fauchey V, Slowinski F, Pichat P, Dargazanli G, Abouabdellah A, Cohen C, Bergis OE (2018) The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents. Sci Rep 8:2416

    Article  PubMed  PubMed Central  Google Scholar 

  • Gunduz-Cinar O, Hill MN, McEwen BS, Holmes A (2013a) Amygdala FAAH and anandamide: mediating protection and recovery from stress. Trends Pharmacol Sci 34:637–644

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gunduz-Cinar O, MacPherson KP, Cinar R, Gamble-George J, Sugden K, Williams B, Godlewski G, Ramikie TS, Gorka AX, Alapafuja SO, Nikas SP, Makriyannis A, Poulton R, Patel S, Hariri AR, Caspi A, Moffitt TE, Kunos G, Holmes A (2013b) Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Mol Psychiatry 18:813–823

    Article  CAS  PubMed  Google Scholar 

  • Helpman L, Marin MF, Papini S, Zhu X, Sullivan GM, Schneier F, Neria M, Shvil E, Malaga Aragon MJ, Markowitz JC, Lindquist MA, Wager T, Milad M, Neria Y (2016) Neural changes in extinction recall following prolonged exposure treatment for PTSD: A longitudinal fMRI study. Neuroimage Clin 12:715–723

    Article  PubMed  PubMed Central  Google Scholar 

  • Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A 87:1932–1936

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hill MN, Patel S (2013) Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses. Biol Mood Anxiety Disord 3:19

    Article  PubMed  PubMed Central  Google Scholar 

  • Hill MN, McLaughlin RJ, Morrish AC, Viau V, Floresco SB, Hillard CJ, Gorzalka BB (2009) Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis. Neuropsychopharmacology 34:2733–2745

    Article  CAS  PubMed  Google Scholar 

  • Hill MN, McLaughlin RJ, Bingham B, Shrestha L, Lee TT, Gray JM, Hillard CJ, Gorzalka BB, Viau V (2010a) Endogenous cannabinoid signaling is essential for stress adaptation. Proc Natl Acad Sci U S A 107:9406–9411

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hill MN, Patel S, Campolongo P, Tasker JG, Wotjak CT, Bains JS (2010b) Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output. J Neurosci 30:14980–14986

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hill MN, Bierer LM, Makotkine I, Golier JA, Galea S, McEwen BS, Hillard CJ, Yehuda R (2013a) Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks. Psychoneuroendocrinology 38:2952–2961

    Article  CAS  PubMed  Google Scholar 

  • Hill MN, Kumar SA, Filipski SB, Iverson M, Stuhr KL, Keith JM, Cravatt BF, Hillard CJ, Chattarji S, McEwen BS (2013b) Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure. Mol Psychiatry 18:1125–1135

    Article  CAS  PubMed  Google Scholar 

  • Hoskins M, Pearce J, Bethell A, Dankova L, Barbui C, Tol WA, van Ommeren M, de Jong J, Seedat S, Chen H, Bisson JI (2015) Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis. Br J Psychiatry 206:93–100

    Article  PubMed  Google Scholar 

  • Ivy D, Palese F, Vozella V, Fotio Y, Yalcin A, Ramirez G, Mears D, Wynn G, Piomelli D (2020) Cannabinoid CB2 receptors mediate the anxiolytic-like effects of monoacylglycerol lipase inhibition in a rat model of predator-induced fear. Neuropsychopharmacology 45:1330–1338

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, Giustino A, Tattoli M, Palmery M, Cuomo V, Piomelli D (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9:76–81

    Article  CAS  PubMed  Google Scholar 

  • Lim J, Igarashi M, Jung KM, Butini S, Campiani G, Piomelli D (2016) Endocannabinoid Modulation of Predator Stress-Induced Long-Term Anxiety in Rats. Neuropsychopharmacology 41:1329–1339

    Article  CAS  PubMed  Google Scholar 

  • Lin HC, Mao SC, Gean PW (2006) Effects of intra-amygdala infusion of CB1 receptor agonists on the reconsolidation of fear-potentiated startle. Learn Mem 13:316–321

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lin HC, Mao SC, Su CL, Gean PW (2009) The role of prefrontal cortex CB1 receptors in the modulation of fear memory. Cereb Cortex 19:165–175

    Article  CAS  PubMed  Google Scholar 

  • Mayo LM, Asratian A, Linde J, Morena M, Haataja R, Hammar V, Augier G, Hill MN, Heilig M (2020) Elevated Anandamide, Enhanced Recall of Fear Extinction, and Attenuated Stress Responses Following Inhibition of Fatty Acid Amide Hydrolase: A Randomized, Controlled Experimental Medicine Trial. Biol Psychiatry 87:538–547

    Article  PubMed  Google Scholar 

  • Mayo LM, Rabinak CA, Hill MN, Heilig M (2022) Targeting the Endocannabinoid System in the Treatment of Posttraumatic Stress Disorder: A Promising Case of Preclinical-Clinical Translation? Biol Psychiatry 91:262–272

    Article  CAS  PubMed  Google Scholar 

  • Moise AM, Eisenstein SA, Astarita G, Piomelli D, Hohmann AG (2008) An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters. Psychopharmacology 200:333–346

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Moreira FA, Kaiser N, Monory K, Lutz B (2008) Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Neuropharmacology 54:141–150

    Article  CAS  PubMed  Google Scholar 

  • Morena M, Patel S, Bains JS, Hill MN (2016) Neurobiological Interactions Between Stress and the Endocannabinoid System. Neuropsychopharmacology 41:80–102

    Article  CAS  PubMed  Google Scholar 

  • Neumeister A, Normandin MD, Pietrzak RH, Piomelli D, Zheng MQ, Gujarro-Anton A, Potenza MN, Bailey CR, Lin SF, Najafzadeh S, Ropchan J, Henry S, Corsi-Travali S, Carson RE, Huang Y (2013) Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. Mol Psychiatry 18:1034–1040

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Newsom RJ, Osterlund C, Masini CV, Day HE, Spencer RL, Campeau S (2012) Cannabinoid receptor type 1 antagonism significantly modulates basal and loud noise induced neural and hypothalamic-pituitary-adrenal axis responses in male Sprague-Dawley rats. Neuroscience 204:64–73

    Article  CAS  PubMed  Google Scholar 

  • Patel S, Hillard CJ (2008) Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation. Eur J Neurosci 27:2821–2829

    Article  PubMed  PubMed Central  Google Scholar 

  • Pellow S, Chopin P, File SE, Briley M (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–167

    Article  CAS  PubMed  Google Scholar 

  • Piomelli D, MabouTagne A (2022) Endocannabinoid-Based Therapies. Annu Rev Pharmacol Toxicol 62:483–507

    Article  PubMed  Google Scholar 

  • Ramot A, Akirav I (2012) Cannabinoid receptors activation and glucocorticoid receptors deactivation in the amygdala prevent the stress-induced enhancement of a negative learning experience. Neurobiol Learn Mem 97:393–401

    Article  CAS  PubMed  Google Scholar 

  • Rauch SAM, Kim HM, Powell C, Tuerk PW, Simon NM, Acierno R, Allard CB, Norman SB, Venners MR, Rothbaum BO, Stein MB, Porter K, Martis B, King AP, Liberzon I, Phan KL, Hoge CW (2019) Efficacy of Prolonged Exposure Therapy, Sertraline Hydrochloride, and Their Combination Among Combat Veterans With Posttraumatic Stress Disorder: A Randomized Clinical Trial. JAMA Psychiat 76:117–126

    Article  Google Scholar 

  • Renner V, Schellong J, Bornstein S, Petrowski K (2022) Stress-induced pro- and anti-inflammatory cytokine concentrations in female PTSD and depressive patients. Transl Psychiatry 12:158

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rodgers RJ, Dalvi A (1997) Anxiety, defence and the elevated plus-maze. Neurosci Biobehav Rev 21:801–810

    Article  CAS  PubMed  Google Scholar 

  • Schnurr PP, Friedman MJ, Engel CC, Foa EB, Shea MT, Chow BK, Resick PA, Thurston V, Orsillo SM, Haug R, Turner C, Bernardy N (2007) Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA 297:820–830

    Article  CAS  PubMed  Google Scholar 

  • Schwendt M, Shallcross J, Hadad NA, Namba MD, Hiller H, Wu L, Krause EG, Knackstedt LA (2018) A novel rat model of comorbid PTSD and addiction reveals intersections between stress susceptibility and enhanced cocaine seeking with a role for mGlu5 receptors. Transl Psychiatry 8:209

    Article  PubMed  PubMed Central  Google Scholar 

  • Shallcross J, Hamor P, Bechard AR, Romano M, Knackstedt L, Schwendt M (2019) The Divergent Effects of CDPPB and Cannabidiol on Fear Extinction and Anxiety in a Predator Scent Stress Model of PTSD in Rats. Front Behav Neurosci 13:91

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Spagnolo PA, Ramchandani VA, Schwandt ML, Kwako LE, George DT, Mayo LM, Hillard CJ, Heilig M (2016) FAAH Gene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence. Alcohol Clin Exp Res 40:2426–2434

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Staples LG (2010) Predator odor avoidance as a rodent model of anxiety: learning-mediated consequences beyond the initial exposure. Neurobiol Learn Mem 94:435–445

    Article  PubMed  Google Scholar 

  • Stopponi S, Fotio Y, Domi A, Borruto AM, Natividad L, Roberto M, Ciccocioppo R, Cannella N (2018) Inhibition of fatty acid amide hydrolase in the central amygdala alleviates co-morbid expression of innate anxiety and excessive alcohol intake. Addict Biol 23:1223–1232

    Article  CAS  PubMed  Google Scholar 

  • Verbitsky A, Dopfel D, Zhang N (2020) Rodent models of post-traumatic stress disorder: behavioral assessment. Transl Psychiatry 10:132

    Article  PubMed  PubMed Central  Google Scholar 

  • Wiley JL, Dewey MA, Jefferson RG, Winckler RL, Bridgen DT, Willoughby KA, Martin BR (2000) Influence of phenylmethylsulfonyl fluoride on anandamide brain levels and pharmacological effects. Life Sci 67:1573–1583

    Article  CAS  PubMed  Google Scholar 

  • Willoughby KA, Moore SF, Martin BR, Ellis EF (1997) The biodisposition and metabolism of anandamide in mice. J Pharmacol Exp Ther 282:243–247

    CAS  PubMed  Google Scholar 

  • Yasmin F, Colangeli R, Morena M, Filipski S, van der Stelt M, Pittman QJ, Hillard CJ, Teskey GC, McEwen BS, Hill MN, Chattarji S (2020) Stress-induced modulation of endocannabinoid signaling leads to delayed strengthening of synaptic connectivity in the amygdala. Proc Natl Acad Sci U S A 117:650–655

    Article  CAS  PubMed  Google Scholar 

  • Yehuda R, Hoge CW, McFarlane AC, Vermetten E, Lanius RA, Nievergelt CM, Hobfoll SE, Koenen KC, Neylan TC, Hyman SE (2015) Post-traumatic stress disorder. Nat Rev Dis Primers 1:15057

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Kayla Chang and Cecilia Thien Dang assisted during behavioral experiments.

Funding

This work was supported by a contract from Endosane Pharmaceuticals GmbH (to DP). The company was not involved in the study's design, execution, or data analysis.

Author information

Authors and Affiliations

  1. Department of Anatomy and Neurobiology, University of California, Irvine, CA, 92697, USA

    Yannick Fotio, Alex Mabou Tagne, Kwang-Mook Jung & Daniele Piomelli

  2. Department of Biological Chemistry, University of California, Irvine, CA, 92697, USA

    Daniele Piomelli

  3. Department of Pharmaceutical Sciences, University of California, Irvine, CA, 92697-4625, USA

    Daniele Piomelli

Authors
  1. Yannick Fotio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alex Mabou Tagne
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kwang-Mook Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniele Piomelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

This study was ideated and designed by DP. The experiments were conducted by YF, AMT, and K-MJ. YF performed statistical analyses. YF wrote and DP edited the manuscript. All the authors reviewed and approved it.

Corresponding author

Correspondence to Daniele Piomelli.

Ethics declarations

Competing interest

D.P. is an inventor in patent applications, owned by the Regents of the University of California, which protect the composition and use of ARN14663, ARN14280, and other FAAH inhibitors.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article belongs to a Special Issue on Cannabis and Cannabinoids

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fotio, Y., Mabou Tagne, A., Jung, KM. et al. Fatty acid amide hydrolase inhibition alleviates anxiety-like symptoms in a rat model used to study post-traumatic stress disorder. Psychopharmacology (2023). https://doi.org/10.1007/s00213-023-06358-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00213-023-06358-y

Keywords

search

Navigation